Related Experiment Videos

Immune thrombocytopenia during interferon-alfa therapy for renal cell carcinoma

Shusuke Akamatsu1, Akira Asazuma, Sojun Kanamaru

  • 1The Department of Urology, Nishi-Kobe Medical Center.

Hinyokika Kiyo. Acta Urologica Japonica
|November 30, 2006
PubMed

Insights

Immune thrombocytopenia is a rare side effect of interferon-alfa (IFN-alpha) therapy. This case study shows that stopping IFN-alpha and using corticosteroids can reverse this complication, with no recurrence upon re-challenge with a different IFN-alpha subtype.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Interferon-alfa (IFN-alpha) is used to treat renal cell carcinoma.
  • Immune thrombocytopenia is a rare but serious complication associated with IFN-alpha therapy.

Observation:

  • A patient with renal cell carcinoma developed severe thrombocytopenia during treatment with purified IFN-alpha.
  • Diagnostic evaluation, including bone marrow biopsy, confirmed drug-induced immune thrombocytopenia.
  • Platelet counts recovered promptly after discontinuing IFN-alpha and initiating corticosteroid treatment.

Findings:

  • The patient was subsequently re-challenged with a different subtype, recombinant IFN-alpha-2b, under close monitoring.
  • No severe thrombocytopenia recurred upon re-exposure to the alternative IFN-alpha subtype.
  • This suggests a lack of cross-reactivity between different IFN-alpha subtypes in inducing immune thrombocytopenia.

Implications:

  • This case highlights the importance of recognizing immune thrombocytopenia as a potential adverse effect of IFN-alpha.
  • It suggests that switching to a different IFN-alpha subtype may be a viable strategy for patients who develop this complication.
  • Further research into the immunogenic differences between IFN-alpha subtypes is warranted.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...